Today's Healthcare Pulse

FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
BCBSNC Foundation Marks 25 Years, With Local Health Priorities Mirroring National Trends
To mark its 25th anniversary, the Blue Cross and Blue Shield of North Carolina Foundation highlighted its three priority areas—expanding access to care, leveraging food as medicine, and improving youth mental health. Over the past quarter‑century the Foundation has deployed more than $269 million in grants, partnering with over 1,700 nonprofits across all 100 counties. The initiative targets high‑cost health drivers, such as diet‑related chronic disease projected to cost $65 billion, and the mental‑health crisis affecting 40% of state high‑school students, many of whom lack local psychiatric services. By convening providers, community health workers, and policy makers, the Foundation aims to lower long‑term health‑care costs and improve outcomes statewide.

Smoking May Spark Reaction Tied to Dementia
A University of Chicago team discovered that nicotine triggers a previously unknown lung‑brain signaling pathway. Pulmonary neuroendocrine cells (PNECs) release exosomes packed with serotransferrin, which upset iron regulation in neurons and spark oxidative damage linked to dementia. The researchers created...

A Popular Senolytic Treatment Causes Brain Damage in Mice
A recent PNAS study shows that the widely used senolytic cocktail dasatinib plus quercetin (D+Q) impairs myelination in the mouse corpus callosum. The treatment altered oligodendrocyte morphology within minutes, reduced myelin thickness, and triggered endoplasmic reticulum stress, without killing the...

Discovery May Upend Ideas About the Cause of Hydrocephalus
New research led by Stony Brook neurosurgeon Michael Egnor challenges the century‑old belief that hydrocephalus results from impaired cerebrospinal fluid absorption. The team proposes that failure to absorb pulsatile energy from the heartbeat—described as a malfunction of the cerebral windkessel...
Apple Vision Pro Enables First Spatial-Computing Cataract Surgery
An ophthalmologist in San Diego just performed the first Apple Vision Pro-assisted cataract eye surgery. Dr. Tommy Korn (aka medicine's first "chief spatial computing medical officer") did it as part of a clinical study. Main benefits are easy access to patient info (visual...
Multiple Myeloma Sequencing Evolves With CAR T, MRD Insights: Sylvester Homsy, MD
At an Institute for Value‑Based Medicine event in Charlotte, Sylvester Homsy, MD highlighted how CAR‑T cell therapy and bispecific antibodies are reshaping multiple myeloma treatment sequencing. The emergence of B‑cell maturation antigen‑targeted agents is prompting clinicians to consider these high‑efficacy...

CDR vs ACDF in the Back to Work Sweepstakes. Who Wins?
A new meta‑analysis of 16 randomized trials involving more than 5,600 patients compares anterior cervical discectomy and fusion (ACDF) with cervical disc replacement (CDR). The data show CDR patients return to work significantly faster – 33% more likely at six...

Why Microbot Medical Developed a Fully Disposable Surgical Robot
Microbot Medical received FDA 510(k) clearance in September 2025 for its fully disposable Liberty surgical robot, designed for peripheral endovascular navigation. The single‑use system combines a compact drive unit, remote controller, and mounting arm that can be set up in...

Study Finds Season of Entry Impacts Childhood Obesity Outcomes
A secondary analysis of New Zealand’s Whānau Pakari program examined 397 children aged 3.7‑16.8 years to determine whether the season of enrollment influences six‑month BMI outcomes. Overall, 68% reduced their BMI‑SD score by an average of 0.16, but spring entrants showed no significant...
US Pricing Reform Reshapes Drug Launch Strategies: Dee Chaudhary
U.S. drug‑pricing reforms, especially the Most Favored Nation (MFN) rule, are forcing manufacturers to align American prices with the lowest prices offered abroad. As a result, firms are pulling back from launches in France, Germany and the Nordic region to...

Scientists Uncover a Hidden Mechanism Cancer Cells Use to Rewrite Genetic Messages, Revealing a Promising New Target for Treatment
A team of molecular biologists has uncovered a previously unknown RNA‑binding protein that rewrites messenger‑RNA messages in cancer cells, effectively reprogramming gene expression. The discovery explains how tumors can rapidly adapt to hostile environments and develop resistance to standard chemotherapy....

How Age, Sex, and Cancer Type Shape the Risk of New Cancers in Survivors
A new epidemiological study of more than 1.2 million cancer survivors reveals that age, sex, and the original cancer type dramatically influence the likelihood of developing a second primary malignancy. Survivors over 65 face up to a 60% higher risk,...
Pasadena Clinic Received $34 Million in Medicare Skin Graft Scam, Court Documents Say
Federal prosecutors seized over $2 million from Expert Wound Care, a Pasadena clinic accused of billing Medicare $34 million for skin‑graft procedures that patients never received. The scheme involved 78 beneficiaries, with a single patient billed more than $6 million. Medicare’s spending on...

Medicare Won’t Cover It: 5 Common Health Expenses That May Blindside Retirees
Medicare leaves significant gaps that can surprise retirees, especially for routine dental, vision and hearing services that are largely excluded from Original Medicare. The most costly omission is long‑term care, with a 65‑year‑old needing roughly $135,000 to cover future expenses,...
Hospitals Prioritize Profit Over People in Health Policy
Quick reminder that hospitals are not on the side of the people when it comes to health policy
With Cell and Gene Therapies Proliferation, Specialty Pharmacy Faces New Pricing, Distribution Pressures
Cell and gene therapies are moving from ultra‑rare indications to broader patient populations, prompting a fundamental redesign of specialty‑pharmacy distribution and pricing models. At the 2026 Asembia meeting, experts warned that current flash‑title and buy‑and‑bill channels may not scale to...

New Clinical Guidelines Significantly Reduce Opioid Prescriptions After Ear Surgery
A retrospective analysis of more than 25,000 patients across 80 U.S. health systems shows that the American Academy of Otolaryngology‑Head and Neck Surgery Foundation’s opioid prescribing guideline, released in April 2021, immediately reduced postoperative opioid prescriptions after parotidectomy. Data from the...

Pharmaceutical Executive Daily: FDA Approves Breztri
Sun Pharmaceutical Industries agreed to buy Organon for $11.75 billion, propelling the combined entity into the top‑25 global pharma ranks. IMG Pharmaceutical announced the acquisition of Japan’s Matsumoto Pharmaceutical, adding a portfolio with more than 50 OTC approvals. The FDA granted...

VCU Study Identifies Key Factors Driving Risk of Second Cancers
Researchers at Virginia Commonwealth University examined data from more than 3 million U.S. cancer survivors spanning 1975‑2019, revealing that the likelihood of a second primary cancer depends heavily on age at initial diagnosis, sex, and the type of first cancer. Older...

How Price Transparency Could Fix the Abandoned Rx Issue: Laura Jensen
GoodRx’s chief commercial officer Laura Jensen argued that greater drug‑price transparency could dramatically cut the roughly one billion annual abandoned prescriptions in the United States. Speaking at Asembia’s AXS26 conference, she highlighted how transparent, consumer‑facing platforms can deliver easier‑to‑access discounts for...
Endurance Exercise Protects Joints, Boosts Fat Oxidation
Ha... no. He's wrong. Yes, there's an Afib signal. But his other conclusions... no. Run and cycle... we know why we do it... and my patients who run/ride are by far better off than those who don't. You need...
Proposing Medicare Over Medicaid for Home-Based Long-Term Care
My look at a plan to shift home and community based long-term care from Medicaid to Medicare https://t.co/kIHQ5jBHJ3 #medicare #medicaid #seniors #hcbs #longtermcare #peoplewithdisabilities

New AI Models Quickly Find Compounds that Target Lyme Bacteria
Tufts University researchers have leveraged AI and machine‑learning to rapidly pinpoint narrow‑spectrum antibiotics that kill the Lyme disease bacterium Borrelia burgdorferi. Screening 60,000 existing compounds yielded several hundred hits, and generative models now explore an estimated 10^60 drug‑like molecules to...
FDA Partners with AZN, AMGN to Accelerate AI-Driven Trials
FDA launches effort with $AZN $AMGN to speed up clinical trials, using AI https://t.co/k4LjxnDLmq via @LizzyLaw_
Supreme Court Case Could Broaden Vascepa Generic Labeling
Vascepa "skinny label" generic case at the Supreme Court. The generic label is only for hypertriglyceridemia, while Vascepa label is much broader. But gets promoted as a generic for Vascepa. Impact might be substantial. https://t.co/xtGWtscXkc

Implant Trade Secrets Are Not Protectable Due to Disclosure in Patents
The Federal Circuit ruled that trade secrets disclosed in patents are unprotectable under the California Uniform Trade Secrets Act, reversing a district court decision in International Medical Devices, Inc. v. Cornell. The court found three of IMD’s alleged secrets “generally...
Medevac Helicopters Use Roadside LZs for Familiarization Flights
There are a lot of reasons a helo, esp a medevac, would land next to a road. One common reason is that medical helicopters will conduct familiarization flights and land at pre-approved LZs (some of which are private) in their...

Breaking: Fauci’s Top Advisor Charged in COVID Cover-Up Case
David Morens, a longtime senior advisor to Dr. Anthony Fauci, was indicted by the Department of Justice on charges of conspiracy and destruction of federal records. Prosecutors allege he used private email accounts to move COVID‑related discussions off official systems,...

Advanced Gene Editing ‘Promising’ for Sickle Cell Disease
Two recent New England Journal of Medicine studies demonstrate that CRISPR‑Cas12a (reni‑cel) and base‑editing (risto‑cel) autologous stem‑cell therapies can dramatically raise fetal hemoglobin and normalize total hemoglobin in sickle cell patients. The RUBY trial reported a rise from 2.5% to...

Human-Centered Digital Transformation in Specialty Pharmacy
At the AXS26 Summit, AcariaHealth executives outlined a human‑centered digital transformation for specialty pharmacy that streamlines workflows while keeping personal clinician contact. They showcased a secure‑messaging onboarding process that trims a typical 45‑minute intake call to a brief exchange and...

Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs
At the Asembia AXS26 Summit, Clarivate’s Dee Chaudhary warned that U.S. drug‑pricing policy is moving from theory to real‑time execution, reshaping payer behavior and market volatility. The Inflation Reduction Act’s Medicare price negotiations, the new One Big, Beautiful Bill Act, and renewed Most Favored...

FDA Debuts Plan to Collect Real-Time Clinical Trial Data
The U.S. Food and Drug Administration announced a pilot program that will collect clinical‑trial data in real time, allowing scientific reviewers to see information as it is generated. The initiative, launched on Tuesday, includes participation from major drugmakers AstraZeneca and...

How to Implement AI-Powered Coronary Plaque Analysis Software—And Ensure You Get Paid
Artificial intelligence is now being used to analyze coronary plaque in CT angiography, offering detailed, non‑invasive assessments of coronary artery disease. Medicare expanded coverage and introduced Category 1 CPT codes in 2024, allowing providers to be reimbursed for AI‑driven plaque analysis....

Aylward Enterprises Highlights Custom Packaging Automation Solutions for Complex Solid-Dose Applications
Aylward Enterprises showcased its Custom Packaging Automation portfolio, targeting complex oral solid‑dose (OSD) products such as quick‑dissolve capsules, softgels, and irregularly shaped tablets. Leveraging proprietary feeding, filling and robotic technologies, the company delivers integrated lines that move blisters to cartoners,...

Federated Machine Learning Gives Healthcare Organizations a Competitive AI Advantage
Federated machine learning lets health systems train AI models on‑site, sending only model updates to a central server. This decentralized approach preserves patient privacy while aggregating insights from multiple hospitals, such as Mayo Clinic and Vanderbilt University, using NVIDIA‑powered platforms....
GLP-1 Receptor Agonist Add-On at Immune Checkpoint Inhibitor Initiation and Fewer Wasting-Related Diagnoses and Acute-Care Episodes in People with Cancer...
A target‑trial emulation of US TriNetX data examined cancer patients with obesity who started immune checkpoint inhibitors (ICIs) and received a GLP‑1 receptor agonist (GLP‑1 RA) at initiation. After 1:1 propensity matching, 988 patients per arm were followed for up to...

Cutting Cancer Care Costs, Rethinking ACA Policy: Justin Favaro, MD
At the Institute for Value‑Based Medicine conference in Charlotte, oncologist Justin Favaro highlighted how independent oncology practices can dramatically lower chemotherapy costs and deliver care at roughly $1,000 per Medicare patient in annual savings. He noted that health‑care now accounts...

Trump Admin Revives COVID Origins Debate with Indictment
The Justice Department has indicted David Morens, a former senior adviser at the National Institute of Allergy and Infectious Diseases, on conspiracy and record‑tampering charges for allegedly deleting emails and routing communications to a personal account to hide information about...
Reproductive Health Service Utilization and Associated Factors Among Womens With Disabilities in Gedeo Zone, Southern Ethiopia: Cross-Sectional Study
A cross‑sectional study of 605 women with disabilities in Ethiopia’s Gedeo Zone found that only 15.7% accessed sexual and reproductive health (SRH) services in the past year. The majority were single, rural, and physically impaired, with 94.5% not using family‑planning...
Two Tiers Too Many. Re: Doctors’ Distinct Work and Professional Role Can’t Be Parcelled Into Generic Tasks for “Tiers” Of...
A BMJ letter from retired consultant psychiatrist David Bowker argues that the NHS’s push toward generic “tiers” of healthcare staff erodes the distinct professional role of doctors. He cites the experience of psychiatrists trained in the 1970s who later faced...
Pfizer Secures Patent Extension for Leading Rare‑Disease Drug
Pfizer deals extend patent life for a top-selling rare disease drug https://t.co/uXXbtLaIOL $PFE $BBIO $ALNY $IONS

Pfizer Delays Patent Cliff for Blockbuster Vyndamax
Pfizer announced a two‑year extension of market exclusivity for Vyndamax (tafamidis), pushing the expected generic launch to 2026. The extension stems from a new formulation patent and a pediatric study that grant additional protection. Vyndamax, approved for transthyretin amyloid cardiomyopathy,...
Dual-Agonist Survodutide Shows Significant Weight Loss in Phase III Obesity Trial
Boehringer Ingelheim reported that its dual glucagon/GLP‑1 agonist survodutide produced up to 16.6% average weight loss after 76 weeks in the Phase III SYNCHRONIZE‑1 trial. The study also showed that 85.1% of treated participants achieved at least a 5% reduction, with...

What’s the Actual Neurological Cost of a 3-Column Osteotomy?
A prospective multicenter study of 553 adult spinal deformity patients found that 130 (23.5%) underwent a three‑column osteotomy (3CO). Neurologic adverse events occurred in 23.1% of 3CO cases versus 15.4% without a 3CO, a statistically significant increase. Despite the higher...
Tiny Chip Delivers High‑Bandwidth Wireless Brain Interface
Ultra-Compact Brain–Computer Interface Chip Enables High-Bandwidth Wireless Neural Communication by @CUSEAS #MedTech #Healthcare #HealthTech #Tech #Technology https://t.co/gaulMV302i

Uveitis Attack History May Predict Cataract Surgery Outcomes
Researchers at Turkey's Uak Training and Research Hospital examined 54 eyes with uveitis‑associated cataracts that underwent phacoemulsification and intra‑ocular lens implantation. Each additional uveitis attack added roughly 1.29 days to postoperative topical steroid therapy and was modestly linked to poorer...
Psychedelics May Reverse Epigenetic Roots of Addiction
Epigenetic Mechanisms of Psychedelics in Addiction: Emerging Evidence and Therapeutic Potential these compounds may directly counteract the epigenetic and transcriptional imprints that sustain compulsive substance use https://t.co/GJyHoLPL83

Hikma and Amarin's Generic Drug Case Heads to Supreme Court Arguments
The U.S. Supreme Court will hear arguments this week in the dispute between Hikma Pharmaceuticals and Amarin over a prescription‑strength fish‑oil pill, the first generic challenge to Amarin’s Vascepa. The case centers on whether the FDA’s bioequivalence standards and the...
BIOTECanada Responds to Health Canada’s Gazette on a Draft Order Providing for Reliance on International Regulatory Authorities
Health Canada’s Gazette released a draft Order that would allow Canadian regulators to rely on approvals from trusted foreign agencies, a key component of the Red Tape Review initiative. BIOTECanada praised the proposal, calling it a meaningful step toward faster...

PCI Benefits Stable Patients More in Focal vs Diffuse Disease: ORBITA-2
A new ORBITA‑2 sub‑analysis shows that patients with focal coronary disease experience markedly greater angina relief from PCI than those with diffuse disease. Using pressure‑wire iFR pullbacks, investigators found an odds ratio of 1.80 for symptom improvement and 1.55 for...